HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection.

Abstract
The aim of the present study was to investigate, in 152 Spanish patients infected with hepatitis C virus (HCV), the possibility that killer cell immunoglobulin-like receptors (KIRs) influence progression to hepatocellular carcinoma. KIRs are related to the activation and inhibition of natural killer cells and may play an important role in the innate response against infection with such viruses as HCV. We found that the human leukocyte antigen-Bw4I80 epitope and the KIR3DS1 gene were more frequent in HCV carriers than in patients with hepatocellular carcinoma. Moreover, these associations were not independent of each other--the KIR3DS1/Bw4I80 genotype clearly was also more frequent in HCV carriers (odds ratio, 24.22).
AuthorsAntonio López-Vázquez, Luis Rodrigo, Jesus Martínez-Borra, Ramón Pérez, Manuel Rodríguez, Juan L Fdez-Morera, Dolores Fuentes, Sandra Rodríguez-Rodero, Segundo Gonzáez, Carlos López-Larrea
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 192 Issue 1 Pg. 162-5 (Jul 01 2005) ISSN: 0022-1899 [Print] United States
PMID15942906 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes
  • HLA-B Antigens
  • HLA-Bw4 antigen
  • Receptors, Immunologic
  • Receptors, KIR
  • Receptors, KIR3DS1
Topics
  • Adult
  • Aged
  • Carcinoma, Hepatocellular (genetics, immunology)
  • Disease Progression
  • Epitopes (genetics)
  • Female
  • Genotype
  • HLA-B Antigens (genetics)
  • Hepatitis C (genetics, immunology)
  • Humans
  • Killer Cells, Natural (immunology)
  • Liver Cirrhosis (immunology)
  • Male
  • Middle Aged
  • Receptors, Immunologic (genetics)
  • Receptors, KIR
  • Receptors, KIR3DS1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: